144 related articles for article (PubMed ID: 20495366)
1. Genetic polymorphisms in XRCC1 associated with radiation therapy in prostate cancer.
Gao R; Price DK; Dahut WL; Reed E; Figg WD
Cancer Biol Ther; 2010 Jul; 10(1):13-8. PubMed ID: 20495366
[TBL] [Abstract][Full Text] [Related]
2. Ethnic disparities in Americans of European descent versus Americans of African descent related to polymorphic ERCC1, ERCC2, XRCC1, and PARP1.
Gao R; Price DK; Sissung T; Reed E; Figg WD
Mol Cancer Ther; 2008 May; 7(5):1246-50. PubMed ID: 18483312
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of satraplatin and prednisone in patients with metastatic castration-resistant prostate cancer: a pharmacogenetic assessment of outcome and toxicity.
Figg WD; Chau CH; Madan RA; Gulley JL; Gao R; Sissung TM; Spencer S; Beatson M; Aragon-Ching J; Steinberg SM; Dahut WL
Clin Genitourin Cancer; 2013 Sep; 11(3):229-37. PubMed ID: 23684781
[TBL] [Abstract][Full Text] [Related]
4. Distribution and haplotype associations of XPD Lys751Gln, XRCC1 Arg280His and XRCC1 Arg399Gln polymorphisms with nasopharyngeal carcinoma in the Malaysian population.
Visuvanathan S; Chong PP; Yap YY; Lim CC; Tan MK; Lye MS
Asian Pac J Cancer Prev; 2014; 15(6):2747-51. PubMed ID: 24761895
[TBL] [Abstract][Full Text] [Related]
5. Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India.
Sreeja L; Syamala VS; Syamala V; Hariharan S; Raveendran PB; Vijayalekshmi RV; Madhavan J; Ankathil R
J Cancer Res Clin Oncol; 2008 Jun; 134(6):645-52. PubMed ID: 17952468
[TBL] [Abstract][Full Text] [Related]
6.
Meza-Espinoza JP; Peralta-Leal V; Durán-González J; Macías-Gómez N; Bocanegra-Alonso A; Leal-Ugarte E
Genet Res (Camb); 2023; 2023():5565646. PubMed ID: 37829155
[TBL] [Abstract][Full Text] [Related]
7. DNA repair gene X-ray repair cross-complementing group 1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: a study from North India.
Mandal RK; Gangwar R; Mandhani A; Mittal RD
DNA Cell Biol; 2010 Apr; 29(4):183-90. PubMed ID: 20070155
[TBL] [Abstract][Full Text] [Related]
8. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk: a meta-analysis.
Li S; Peng Q; Chen Y; You J; Chen Z; Deng Y; Lao X; Wu H; Qin X; Zeng Z
PLoS One; 2013; 8(9):e73448. PubMed ID: 24039945
[TBL] [Abstract][Full Text] [Related]
9. DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancer.
Rybicki BA; Conti DV; Moreira A; Cicek M; Casey G; Witte JS
Cancer Epidemiol Biomarkers Prev; 2004 Jan; 13(1):23-9. PubMed ID: 14744728
[TBL] [Abstract][Full Text] [Related]
10. Association between polymorphisms in DNA repair genes and survival of non-smoking female patients with lung adenocarcinoma.
Yin Z; Zhou B; He Q; Li M; Guan P; Li X; Cui Z; Xue X; Su M; Ma R; Bai W; Xia S; Jiang Y; Xu S; Lv Y; Li X
BMC Cancer; 2009 Dec; 9():439. PubMed ID: 20003463
[TBL] [Abstract][Full Text] [Related]
11. A meta-analysis on XRCC1 R399Q and R194W polymorphisms, smoking and bladder cancer risk.
Lao T; Gu W; Huang Q
Mutagenesis; 2008 Nov; 23(6):523-32. PubMed ID: 18765423
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case-control study.
Matullo G; Guarrera S; Sacerdote C; Polidoro S; Davico L; Gamberini S; Karagas M; Casetta G; Rolle L; Piazza A; Vineis P
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2569-78. PubMed ID: 16284380
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms and haplotypes of DNA repair genes in childhood acute lymphoblastic leukemia.
Pakakasama S; Sirirat T; Kanchanachumpol S; Udomsubpayakul U; Mahasirimongkol S; Kitpoka P; Thithapandha A; Hongeng S
Pediatr Blood Cancer; 2007 Jan; 48(1):16-20. PubMed ID: 16435384
[TBL] [Abstract][Full Text] [Related]
14. DNA repair genes XPC, XPD, XRCC1, and XRCC3 are associated with risk and survival of squamous cell carcinoma of the head and neck.
Farnebo L; Stjernström A; Fredrikson M; Ansell A; Garvin S; Thunell LK
DNA Repair (Amst); 2015 Jul; 31():64-72. PubMed ID: 26001739
[TBL] [Abstract][Full Text] [Related]
15. XRCC1 R399Q polymorphism and risk of normal tissue injury after radiotherapy in breast cancer patients.
Zhou Y; Zhou W; Liu Q; Fan Z; Yang Z; Tu Q; Li L; Liu H
Tumour Biol; 2014 Jan; 35(1):21-5. PubMed ID: 24292986
[TBL] [Abstract][Full Text] [Related]
16. Pterygium and genetic polymorphisms of the DNA repair enzymes XRCC1, XPA, and XPD.
Chiang CC; Tsai YY; Bau DT; Cheng YW; Tseng SH; Wang RF; Tsai FJ
Mol Vis; 2010 Apr; 16():698-704. PubMed ID: 20431719
[TBL] [Abstract][Full Text] [Related]
17. Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancer.
Burri RJ; Stock RG; Cesaretti JA; Atencio DP; Peters S; Peters CA; Fan G; Stone NN; Ostrer H; Rosenstein BS
Radiat Res; 2008 Jul; 170(1):49-59. PubMed ID: 18582155
[TBL] [Abstract][Full Text] [Related]
18. Assessing tumor mutations to gain insight into base excision repair sequence polymorphisms and smoking in colon cancer.
Curtin K; Samowitz WS; Wolff RK; Ulrich CM; Caan BJ; Potter JD; Slattery ML
Cancer Epidemiol Biomarkers Prev; 2009 Dec; 18(12):3384-8. PubMed ID: 19959686
[TBL] [Abstract][Full Text] [Related]
19. Associated risk of XRCC1 and XPD cross talk and life style factors in progression of head and neck cancer in north Indian population.
Kumar A; Pant MC; Singh HS; Khandelwal S
Mutat Res; 2012 Jan; 729(1-2):24-34. PubMed ID: 21945240
[TBL] [Abstract][Full Text] [Related]
20. XRCC1 and ERCC1 polymorphisms are related to susceptibility and survival of colorectal cancer in the Chinese population.
Dai Q; Luo H; Li XP; Huang J; Zhou TJ; Yang ZH
Mutagenesis; 2015 May; 30(3):441-9. PubMed ID: 25690281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
